PCI Pharma Expands U.S. Sterile Manufacturing Capacity
PHILADELPHIA, PA — PCI Pharma Services announced more than $1 billion in infrastructure investments across its U.S. and European operations, including expanded sterile fill-finish manufacturing, drug-device assembly, and pharmaceutical development …
PCI Pharma Expands U.S. Sterile Manufacturing Capacity Read More